SCHEMBL5222885

SCHEMBL5222885

COc1ccccc1OCC(O)CN1C[CH]N(c2nc3c(Cl)cccc3o2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.49
KMT2A Q03164 6/20 0.49
USP2 O75604 2/20 0.49
HTT P42858 2/20 0.49
MAPT P10636 10/20 0.46
NPSR1 Q6W5P4 4/20 0.46
MAPK1 P28482 3/20 0.45
KDM4E B2RXH2 3/20 0.45
LMNA P02545 6/20 0.44
TDP1 Q9NUW8 2/20 0.44
ADRB1 P08588 2/20 0.44
ADRA2A P08913 2/20 0.44
ADRA2B P18089 2/20 0.44
ADRA2C P18825 2/20 0.44
ADRA1A P35348 2/20 0.44
DRD3 P35462 2/20 0.44
HTR2B P41595 2/20 0.44
KCNH2 Q12809 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2D6 P10635 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6184593 0.86 HRH1 (0.46) MEN1KMT2AUSP2HTTMAPT
SCHEMBL4866602 0.78 CYP3A4 (0.63) MEN1KMT2AUSP2HTTMAPT
SCHEMBL5224373 0.75 IDO1 (0.48) MEN1KMT2AUSP2HTTMAPT
SCHEMBL2332160 0.73 LMNA (0.73) MEN1KMT2AUSP2HTTMAPT
SCHEMBL6207329 0.71 KCNH2 (0.49) MEN1KMT2AUSP2HTTMAPT
SCHEMBL23057178 0.69 LMNA (0.66) MEN1KMT2AUSP2HTTMAPT
SCHEMBL31510205 0.69 LMNA (0.66) MEN1KMT2AUSP2HTTMAPT
SCHEMBL7282171 0.69 KMT2A (0.59) MEN1KMT2AUSP2HTTMAPT
SCHEMBL5223033 0.69 MEN1 (0.47) MEN1KMT2AUSP2HTTMAPT
SCHEMBL15296749 0.68 ADRB2 (0.73) MEN1KMT2AHTTMAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1806346-A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors CV THERAPEUTICS, INC. (US) 2007-07-11 EP disclosed
EP-1567525-A2 SUBSTITUTED PIPERAZINE COMPOUNDS AND THEIR USE AS FATTY ACID OXIDATION INHIBITORS CV THERAPEUTICS, INC. (US) 2005-08-31 EP disclosed
WO-2004052887-A2 SUBSTITUTED PIPERAZINE COMPOUNDS AND THEIR USE AS FATTY ACID OXIDATION INHIBITORS CV THERAPEUTICS, INC. (US) 2004-06-24 WO disclosed